Retinoblastoma in Asia

Mukesh Jain1, Duangnate Rojanaporn2, Bhavna Chawla3

  • 1Shri Bhagwan Mahavir Vitreoretinal Services, Medical Research Foundation, Sankara Nethralaya, Chennai, 600006, Tamil Nadu, India.

Eye (London, England)
|November 3, 2018
PubMed

Insights

Retinoblastoma (RB) significantly impacts the Asia-Pacific region, with 43% of global cases concentrated there. Addressing socio-economic disparities is crucial for improving culturally relevant and economically feasible interventions for this childhood cancer.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Global Health

Background:

  • The Asia-Pacific region shoulders a substantial global burden of retinoblastoma (RB), a significant childhood eye cancer.
  • In 2013, 43% of global RB cases occurred in six Asia-Pacific countries, highlighting regional disparities.
  • Technological and socio-economic variations within the region contribute to diverse clinical presentations and survival rates.

Purpose of the Study:

  • To underscore the importance of understanding retinoblastoma in the Asia-Pacific region.
  • To identify socio-economic challenges and opportunities for intervention development.
  • To propose actionable steps for improving RB care and outcomes in developing nations.

Main Methods:

  • Analysis of 2013 population estimates to determine the global burden of retinoblastoma.
  • Review of existing literature on technological and socio-economic disparities in the region.
  • Identification of potential strategies for disease management and intervention.

Main Results:

  • India and China account for the highest numbers of retinoblastoma cases in the region.
  • Significant disparities in clinical presentation and survival rates exist due to socio-economic factors.
  • Challenges in managing retinoblastoma are multifaceted, encompassing technological, social, and economic aspects.

Conclusions:

  • Effective interventions for retinoblastoma in the Asia-Pacific must be culturally relevant and economically feasible.
  • Key strategies include disease education, universal screening, subsidized treatment, and enhanced healthcare infrastructure.
  • Developing specialized centers with tele-ophthalmology services can improve access to care and outcomes for children with retinoblastoma.